Engineered Bacteriophage T4 Nanoparticle as a Potential Targeted Activator of HIV-1 Latency in CD4+ Human T-cells

MLA

Neeti Ananthaswamy, et al. Engineered Bacteriophage T4 Nanoparticle as a Potential Targeted Activator of HIV-1 Latency in CD4+ Human T-Cells. July 2021. EBSCOhost, https://doi.org/10.1101/2021.07.20.453091.

APA

Neeti Ananthaswamy, Camille Lange, Haitao Hu, Himanshu Batra, Venigalla B. Rao, Mary F. Kearney, Frank Maldarelli, Jingen Zhu, Marthandan Mahalingam, Pan Tao, Chaojie Zhong, & Swati Jain. (2021). Engineered Bacteriophage T4 Nanoparticle as a Potential Targeted Activator of HIV-1 Latency in CD4+ Human T-cells. https://doi.org/10.1101/2021.07.20.453091

Chicago

Neeti Ananthaswamy, Camille Lange, Haitao Hu, Himanshu Batra, Venigalla B. Rao, Mary F. Kearney, Frank Maldarelli, et al. 2021. “Engineered Bacteriophage T4 Nanoparticle as a Potential Targeted Activator of HIV-1 Latency in CD4+ Human T-Cells,” July. doi:10.1101/2021.07.20.453091.